Aims of this Policy

This policy aims to provide guidance on the precautions which must be taken during clinical procedures and surgery on patients known, suspected or at risk of CJD/TSE, to prevent transmission to others. It also details how instruments and other equipment should be quarantined, decontaminated and/or disposed of.

 

Purpose

To ensure the correct procedures are adhered to prevent any onward transmission.

 

Patient Risk Groups

Patients may be grouped according to whether they have known or suspected CJD/TSE, or are potentially at risk of developing one of these diseases, i.e. who are asymptomatic, but have a clinical or family history which places them in a risk group. The requirements detailed in this policy apply only to patients who fall into one of these groups.

 

Policy Details

Download: PDF version
Compiled by: The Infection Control Team
Ratified by: Clinical Governance Committee
Date Ratified: August 2017
Date Issued: August 2017
Review Date: March 2019
Target Audience: All Trust staff
Contact name: The Infection Control Team

 

See also:

  • Policy for infection control of CJD and other transmissible spongiform encephalopathies (TSE).